These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27417340)

  • 1. Therapeutic monitoring of the immuno-modulating drugs in systemic lupus erythematosus.
    Mok CC
    Expert Rev Clin Immunol; 2017 Jan; 13(1):35-41. PubMed ID: 27417340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin inhibitors in systemic lupus erythematosus.
    Mok CC
    Best Pract Res Clin Rheumatol; 2017 Jun; 31(3):429-438. PubMed ID: 29224682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic lupus erythematosus: review of synthetic drugs.
    Tsang-A-Sjoe MW; Bultink IE
    Expert Opin Pharmacother; 2015; 16(18):2793-806. PubMed ID: 26479437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing the use of existing therapies in lupus.
    Croyle L; Morand EF
    Int J Rheum Dis; 2015 Feb; 18(2):129-37. PubMed ID: 25884457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of assessing medication exposure to the definition of refractory disease in systemic lupus erythematosus.
    Arnaud L; Zahr N; Costedoat-Chalumeau N; Amoura Z
    Autoimmun Rev; 2011 Sep; 10(11):674-8. PubMed ID: 21575744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxychloroquine in systemic lupus erythematosus (SLE).
    Ponticelli C; Moroni G
    Expert Opin Drug Saf; 2017 Mar; 16(3):411-419. PubMed ID: 27927040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil in the treatment of systemic lupus erythematosus.
    Dall'Era M
    Curr Opin Rheumatol; 2011 Sep; 23(5):454-8. PubMed ID: 21720247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypersensitivity to mycophenolate mofetil in systemic lupus erythematosus: diagnostic measures and successful desensitization.
    Szyper-Kravitz M; Sheinberg P; Sidi Y; Schiffenbauer Y; Trubniykov E; Shoenfeld Y
    Int Arch Allergy Immunol; 2005 Dec; 138(4):334-6. PubMed ID: 16224194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure levels of mycophenolic acid are associated with comorbidities in children with systemic lupus erythematosus.
    Ye Q; Wang G; Lu J; Huang Y; Zhang J; Zhu L; Zhu Y; Lan J; Li Z; Liu Y; Xu H; Li Z
    Lupus; 2021 Oct; 30(11):1808-1818. PubMed ID: 34304630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus.
    Djabarouti S; Duffau P; Lazaro E; Chapouly C; Greib C; Viallard JF; Pellegrin JL; Saux MC; Breilh D
    Expert Opin Pharmacother; 2010 Apr; 11(5):689-99. PubMed ID: 20210680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus.
    Galarza-Maldonado C; Kourilovitch MR; Molineros JE; Cardiel MH; Zurita L; Soroka NF; Yagur VY; Doukh N; Cervera R
    Autoimmun Rev; 2010 Dec; 10(2):108-11. PubMed ID: 20804861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus.
    Mak A; Mok CC
    Lupus; 2005; 14(10):856-8. PubMed ID: 16302683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study).
    Costedoat-Chalumeau N; Galicier L; Aumaître O; Francès C; Le Guern V; Lioté F; Smail A; Limal N; Perard L; Desmurs-Clavel H; Boutin du LT; Asli B; Kahn JE; Pourrat J; Sailler L; Ackermann F; Papo T; Sacré K; Fain O; Stirnemann J; Cacoub P; Jallouli M; Leroux G; Cohen-Bittan J; Tanguy ML; Hulot JS; Lechat P; Musset L; Amoura Z; Piette JC;
    Ann Rheum Dis; 2013 Nov; 72(11):1786-92. PubMed ID: 23144449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug monitoring in systemic lupus erythematosus.
    Petri M
    Curr Opin Pharmacol; 2022 Jun; 64():102225. PubMed ID: 35490454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus.
    Costedoat-Chalumeau N; Amoura Z; Hulot JS; Aymard G; Leroux G; Marra D; Lechat P; Piette JC
    Ann Rheum Dis; 2007 Jun; 66(6):821-4. PubMed ID: 17324970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state pharmacokinetics of hydroxychloroquine in patients with cutaneous lupus erythematosus.
    Al-Rawi H; Meggitt SJ; Williams FM; Wahie S
    Lupus; 2018 Apr; 27(5):847-852. PubMed ID: 28862574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus.
    Jallouli M; Galicier L; Zahr N; Aumaître O; Francès C; Le Guern V; Lioté F; Smail A; Limal N; Perard L; Desmurs-Clavel H; Le Thi Huong D; Asli B; Kahn JE; Pourrat J; Sailler L; Ackermann F; Papo T; Sacré K; Fain O; Stirnemann J; Cacoub P; Leroux G; Cohen-Bittan J; Sellam J; Mariette X; Blanchet B; Hulot JS; Amoura Z; Piette JC; Costedoat-Chalumeau N;
    Arthritis Rheumatol; 2015 May; 67(8):2176-84. PubMed ID: 25989906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favorable effects of hydroxychloroquine on serum low density lipid in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
    Babary H; Liu X; Ayatollahi Y; Chen XP; Doo L; Uppaluru LK; Kwak MK; Kulaga C; Modjinou D; Olech E; Yoo JW
    Int J Rheum Dis; 2018 Jan; 21(1):84-92. PubMed ID: 28884965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus.
    Carmichael SJ; Day RO; Tett SE
    Intern Med J; 2013 May; 43(5):547-53. PubMed ID: 23425382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.